Tivic Health Systems, Inc. (NASDAQ:TIVC) Short Interest Down 35.7% in December

Tivic Health Systems, Inc. (NASDAQ:TIVC) was the target of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 152,300 shares, a decrease of 35.7% from the November 30th total of 236,700 shares. Currently, 1.9% of the company’s stock are short sold. Based on an average trading volume of 6,750,000 shares, the short-interest ratio is currently 0.0 days.

Tivic Health Systems Stock Performance

TIVC stock opened at $0.30 on Monday. Tivic Health Systems has a twelve month low of $0.20 and a twelve month high of $2.24. The business has a 50 day moving average price of $0.28 and a two-hundred day moving average price of $0.32.

Hedge Funds Weigh In On Tivic Health Systems

An institutional investor recently bought a new position in Tivic Health Systems stock. Warberg Asset Management LLC acquired a new position in shares of Tivic Health Systems, Inc. (NASDAQ:TIVC) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 80,000 shares of the company’s stock, valued at approximately $31,000. Warberg Asset Management LLC owned about 1.29% of Tivic Health Systems at the end of the most recent reporting period. 4.25% of the stock is owned by institutional investors and hedge funds.

About Tivic Health Systems

Tivic Health Systems Inc operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S.